Free Trial
NASDAQ:TXMD

TherapeuticsMD (TXMD) Stock Price, News & Analysis

TherapeuticsMD logo
$1.18 -0.04 (-3.28%)
As of 11:55 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About TherapeuticsMD Stock (NASDAQ:TXMD)

Key Stats

Today's Range
$1.13
$1.24
50-Day Range
$1.08
$1.52
52-Week Range
$0.70
$2.44
Volume
27,519 shs
Average Volume
160,165 shs
Market Capitalization
$13.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter.

TXMD Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tied to President Trump's Executive Order #14196 could not only rescue Social Security... But also boost benefits by up to 400%, according to legendary investor Louis Navellier.
See More Headlines

TXMD Stock Analysis - Frequently Asked Questions

TherapeuticsMD's stock was trading at $0.86 at the beginning of the year. Since then, TXMD shares have increased by 36.0% and is now trading at $1.17.

TherapeuticsMD, Inc. (NASDAQ:TXMD) issued its earnings results on Tuesday, May, 13th. The company reported ($0.06) earnings per share for the quarter. The firm earned $0.39 million during the quarter. TherapeuticsMD had a negative trailing twelve-month return on equity of 7.86% and a negative net margin of 114.07%.

TherapeuticsMD's stock reverse split on Monday, May 9th 2022.The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TherapeuticsMD investors own include Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
5/13/2025
Today
7/10/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TXMD
Previous Symbol
NYSEMKT:TXMD
CIK
25743
Employees
420
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.18 million
Net Margins
-114.07%
Pretax Margin
-119.61%

Debt

Sales & Book Value

Annual Sales
$1.76 million
Price / Cash Flow
N/A
Book Value
$2.37 per share
Price / Book
0.51

Miscellaneous

Free Float
11,308,000
Market Cap
$14.12 million
Optionable
Optionable
Beta
0.59

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:TXMD) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners